[YMAB] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
07-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 31.39%
YoY- -0.61%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 20,751 20,251 31,447 12,537 10,797 10,486 9,598 67.43%
PBT -6,123 -6,390 1,157 -27,526 -41,131 -28,068 -36,893 -69.89%
Tax 179 -1,293 1,558 1,509 1,186 373 1,135 -70.90%
NP -6,302 -5,097 -401 -29,035 -42,317 -28,441 -36,893 -69.31%
Tax Rate - - -134.66% - - - - -
Total Cost 27,053 25,348 31,848 41,572 53,114 38,927 46,491 -30.36%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -30.37 -25.17 -1.28 -231.59 -391.93 -271.23 -384.38 -81.67%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.14 -0.12 -0.01 -0.66 -0.97 -0.65 -0.85 -70.05%
EPS Diluted -0.14 -0.12 -0.01 -0.66 -0.97 -0.65 -0.85 -70.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.